vs
National Bank Holdings Corp（NBHC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
National Bank Holdings Corp的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$126.8M vs $75.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 14.0%）
这是一家美国区域性银行控股集团，目前在伊利诺伊、印第安纳等八个美国州布局营业网点，拥有近250个金融服务中心与约200家零售分行，总资产达485亿美元。它是总部位于印第安纳州的最大银行控股公司，也跻身美国银行业三十强之列。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NBHC vs PBYI — 直观对比
营收规模更大
NBHC
是对方的1.7倍
$75.5M
两年增速更快
PBYI
近两年复合增速
14.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $126.8M | $75.5M |
| 净利润 | $20.8M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 16.4% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | -14.2% | — |
| 每股收益（稀释后） | $0.46 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NBHCPBYI
| Q1 26 | $126.8M | — | ||
| Q4 25 | $100.6M | $75.5M | ||
| Q3 25 | $108.9M | $54.5M | ||
| Q2 25 | $104.5M | $52.4M | ||
| Q1 25 | $102.1M | $46.0M | ||
| Q4 24 | $101.3M | $59.1M | ||
| Q3 24 | $106.0M | $80.5M | ||
| Q2 24 | $97.6M | $47.1M |
净利润NBHCPBYI
| Q1 26 | $20.8M | — | ||
| Q4 25 | $16.0M | — | ||
| Q3 25 | $35.3M | $8.8M | ||
| Q2 25 | $34.0M | $5.9M | ||
| Q1 25 | $24.2M | $3.0M | ||
| Q4 24 | $28.2M | — | ||
| Q3 24 | $33.1M | $20.3M | ||
| Q2 24 | $26.1M | $-4.5M |
毛利率NBHCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率NBHCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 19.0% | 22.7% | ||
| Q3 25 | 39.6% | 17.6% | ||
| Q2 25 | 39.8% | 12.7% | ||
| Q1 25 | 29.2% | 8.7% | ||
| Q4 24 | 34.3% | 22.6% | ||
| Q3 24 | 37.6% | 27.4% | ||
| Q2 24 | 32.5% | -4.6% |
净利率NBHCPBYI
| Q1 26 | 16.4% | — | ||
| Q4 25 | 15.9% | — | ||
| Q3 25 | 32.4% | 16.2% | ||
| Q2 25 | 32.6% | 11.2% | ||
| Q1 25 | 23.7% | 6.5% | ||
| Q4 24 | 27.8% | — | ||
| Q3 24 | 31.2% | 25.2% | ||
| Q2 24 | 26.8% | -9.6% |
每股收益（稀释后）NBHCPBYI
| Q1 26 | $0.46 | — | ||
| Q4 25 | $0.42 | $0.26 | ||
| Q3 25 | $0.92 | $0.17 | ||
| Q2 25 | $0.88 | $0.12 | ||
| Q1 25 | $0.63 | $0.06 | ||
| Q4 24 | $0.72 | $0.40 | ||
| Q3 24 | $0.86 | $0.41 | ||
| Q2 24 | $0.68 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $472.8M | $97.5M |
| 总债务越低越好 | $202.1M | $22.7M |
| 股东权益账面价值 | $1.7B | $130.3M |
| 总资产 | $12.6B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.12× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NBHCPBYI
| Q1 26 | $472.8M | — | ||
| Q4 25 | $417.1M | $97.5M | ||
| Q3 25 | $555.6M | $94.4M | ||
| Q2 25 | $296.5M | $96.0M | ||
| Q1 25 | $246.3M | $93.2M | ||
| Q4 24 | $127.8M | $101.0M | ||
| Q3 24 | $180.8M | $96.7M | ||
| Q2 24 | $145.0M | $96.8M |
总债务NBHCPBYI
| Q1 26 | $202.1M | — | ||
| Q4 25 | $54.5M | $22.7M | ||
| Q3 25 | $54.7M | $34.0M | ||
| Q2 25 | $54.4M | $45.3M | ||
| Q1 25 | $54.6M | $56.7M | ||
| Q4 24 | $54.5M | $68.0M | ||
| Q3 24 | $54.4M | $79.3M | ||
| Q2 24 | $54.4M | $90.7M |
股东权益NBHCPBYI
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.4B | $130.3M | ||
| Q3 25 | $1.4B | $115.3M | ||
| Q2 25 | $1.4B | $104.7M | ||
| Q1 25 | $1.3B | $97.1M | ||
| Q4 24 | $1.3B | $92.1M | ||
| Q3 24 | $1.3B | $71.1M | ||
| Q2 24 | $1.2B | $48.5M |
总资产NBHCPBYI
| Q1 26 | $12.6B | — | ||
| Q4 25 | $9.9B | $216.3M | ||
| Q3 25 | $10.2B | $202.9M | ||
| Q2 25 | $10.0B | $194.9M | ||
| Q1 25 | $10.1B | $196.2M | ||
| Q4 24 | $9.8B | $213.3M | ||
| Q3 24 | $10.0B | $220.7M | ||
| Q2 24 | $10.0B | $205.0M |
负债/权益比NBHCPBYI
| Q1 26 | 0.12× | — | ||
| Q4 25 | 0.04× | 0.17× | ||
| Q3 25 | 0.04× | 0.30× | ||
| Q2 25 | 0.04× | 0.43× | ||
| Q1 25 | 0.04× | 0.58× | ||
| Q4 24 | 0.04× | 0.74× | ||
| Q3 24 | 0.04× | 1.12× | ||
| Q2 24 | 0.04× | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流NBHCPBYI
| Q1 26 | — | — | ||
| Q4 25 | $162.4M | $14.4M | ||
| Q3 25 | $52.4M | $9.7M | ||
| Q2 25 | $32.3M | $14.1M | ||
| Q1 25 | $39.6M | $3.6M | ||
| Q4 24 | $155.3M | $15.6M | ||
| Q3 24 | $47.0M | $11.0M | ||
| Q2 24 | $31.9M | $1.0M |
自由现金流NBHCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率NBHCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度NBHCPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率NBHCPBYI
| Q1 26 | — | — | ||
| Q4 25 | 10.13× | — | ||
| Q3 25 | 1.48× | 1.10× | ||
| Q2 25 | 0.95× | 2.41× | ||
| Q1 25 | 1.64× | 1.21× | ||
| Q4 24 | 5.51× | — | ||
| Q3 24 | 1.42× | 0.54× | ||
| Q2 24 | 1.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NBHC
| Net Interest Income | $108.8M | 86% |
| Noninterest Income | $18.0M | 14% |
PBYI
暂无分部数据
